期刊文献+

细胞周期蛋白D1反义寡核苷酸调控联合顺铂抑制口腔鳞癌耐药细胞的研究 被引量:2

Inhibition effect on Tca8113/CDDP by antisense oligonucleotides of cyclin D1 combined with cis diamminedichloroplatinum
原文传递
导出
摘要 目的通过体内外实验探讨细胞周期蛋白(cyclinD1)与舌鳞状细胞癌对顺铂(CDDP)耐药细胞系(Tca8113/CDDP)耐药的相关性。方法通过脂质体将cyclinD1正义、反义寡核苷酸序列分别导入Tca8113/CDDP细胞内。用甲基噻唑基四唑(MTT)法检测转染细胞系和耐药细胞系体外生长增殖情况及对顺铂的敏感性。将被转染的细胞及Tca8113/CDDP细胞接种于裸鼠皮下,建立移植瘤模型,共18只,每组6只。给予顺铂腹腔注射治疗,观察移植瘤体积变化,绘制生长曲线;称取瘤重,计算抑瘤率;光镜下观察移植瘤组织病理学变化。结果转导mRNA3′cyclinD1反义寡核苷酸的Tca8113/CDDP细胞在动物体内外生长明显受到顺铂的抑制;裸鼠皮下移植瘤抑瘤率达74%(P<0.05),移植瘤重量较对照组和转导正义寡核苷酸序列组差异均有统计学意义(P<0.05);光镜下可见反义寡核苷酸组移植瘤坏死明显。结论cyclinD1基因的反义调控联合顺铂能抑制Tca8113/CDDP细胞的生长能力及体内移植瘤的生长。研究结果提示:抑制cyclinD1可能增加口腔鳞状细胞癌对顺铂的敏感度。 Objective To clarify the relationship between cyclin D1 and cisplatin resistance of TcaS113/cis diamminedichloreplatinum(CDDP)in vitro and in vivo. Methods We applied the transfection method with plasmids pcDNA3.1-antisense-cyclin D1 by Lipofectamin 2000. TcaS113/CDDP cells were used as control. MTr assay was used to identify the proliferation and sensibility of those cells to cisplatin. Subsequently, 18 nude mice were subcutaneously injected by those cells and divided into 3 groups with 6 mice in each group. Every mouse was treated by cisplatin with 5 mg . kg^-1 . d^-1 for 5 days. The sizes of tumor were measured every other day and were described with the growth curves. After 20 days, tumors were anatomized and weighed. The tumor inhibition ratios were calculated and the HE slides were observed to determine the cell sensibility to cisplatin. Results The transfected cells with pcDNA3.1-antisense-cyclin Dlgrew more slowly than other cells and showed higher sensibility to cisplatin in vitro. The tumors developed by cells with pcDNA3.1-antisense-cyclin D1 were smaller than the The tumor inhibition ratio was 74% (P 〈 0. 05 ). The necrosis area was larger in the tumors developed by the trausfected cells with pcDNA3.1- antisense-cyclin D1 than other groups. Conclusions Antisense oligonucleotides of cyclin D1 can improve the sensibility of TcaS113/CDDP cells to cisplatin and inhibit the growth of tumors.
出处 《中华口腔医学杂志》 CAS CSCD 北大核心 2006年第6期354-357,共4页 Chinese Journal of Stomatology
基金 国家自然科学基金资助项目(30330580 30300388) 上海市重点学科(优势学科)建设基金资助项目(Y0203) 上海市科学技术委员会科研计划基金资助项目(044119619)
关键词 鳞状细胞 细胞周期蛋白D1 寡核苷酸类 反义 顺铂 Carcinoma,squamous cell Cyclin D1 Oligonucleotides,antisense Cisplatin
  • 相关文献

参考文献10

  • 1Serrano M,Hannon GJ,Beach D.A new regulatory motif in cellcyole control causing specific inhibition of cyclin D/CDK4.Nature,1993,366:704-707.
  • 2Mckay JA,Douglas JJ,Ross VG,et al.Analysis of key cell-cycle checkpoint proteins in colorectal tumours.J Pathol,2002,196:386-393.
  • 3周晓健,张萍,潘红芽,陈万涛.Cyclin D1反义寡核苷酸对Tca8113/CDDP细胞基因转录表达的影响[J].上海口腔医学,2005,14(2):169-172. 被引量:4
  • 4周晓健,李卿,陈万涛.人舌鳞状细胞癌顺铂耐药细胞系的建立及其耐药基因表达[J].上海口腔医学,2003,12(6):432-435. 被引量:5
  • 5Namazie A,Alavi S,Olopade OI,et al.Cyclin D1 amplification and p16 (MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.Laryngoscope,2002,112:472-481.
  • 6Jansen B,Zangemeister-Wittke U.Antisense therapy for cancer-the time of truth.Lancet Oncol,2002,3:672-683.
  • 7Yuen AR,Sikic BI.Clinical studies of antisense therapy in cancer.Front Biosci,2000,5:588-593.
  • 8Ho A,Dowdy SF.Regulation of G (1) cell-cycle progression by oncogenes and tumor suppressor genes.Carr Opin Genet Dev,2002,12:47-52.
  • 9Patel V,Senderowicz AM,Pinto D Jr,et al.Flavopiridol,a novel cyclin-dependent kinase inhibitor,suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.J Clin Invest,1998,102:1674-1681.
  • 10Tan AR,Yang X,Berman A,et al.Phase Ⅰ trial of the cyclindependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer.Clin Cancer Res,2004,10:5038-5047.

二级参考文献15

  • 1Ho A, Dowdy SF. Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes[J]. Curr Opin Genet Dev,2002,12(1):47-52.
  • 2Olie RA, Simoes-Wust AP, Baumann B, et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy[J]. Cancer Res,2000,60(11):2805-2809.
  • 3Sczakiel G. The design of antisense RNA[J]. Antisense Nucleic Acid Drug Dev, 1997,7:439-444.
  • 4Wagner RW, Nishikura K. Cell cycle expression of RNA duplex unwinding activity in cells[J]. Mol Cell Biol, 1988,8(2):770-777.
  • 5Antony T, Thomas T, Shirahata A, et al. Selectivity of polyamines on the stability of RNA-DNA hybrids containing phosphodiester and phosphorothicate oligodeoxyribonucleotides[J]. Biochemistry,1999,38(33):10775-10784.
  • 6Gottesman MM.How cancer cells evade chemotherapy:16th Richard and Hnda Foundation Award Lecture [J]. Cancer Res, 1993,53:747-754.
  • 7Misawa T, Kikawa F, Maeda O, et al. Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells [J]. Jpn J Cancer Res,1995,86:88-94.
  • 8Den Boer ML, Pieters R,Kazemier KM, et al. Relationship between major vault protein/lung resistance protein, multidmg resistance associated protein P-glycoprotein, and drug resistance in child leukemia[J]. Blood, 1998,91:2092-2098.
  • 9List A, Spier C, Grogan T, et al. Overexpression of the major vault transporter lung resistance protein predicts treatment outcome in acute myeloid leukemia[J]. Blood, 1996,87:2464-2469.
  • 10Izquierdo M, Van der Zee A, Vermoken J. Drug resistance associated marker LRP for prediction of response to chemotherapy and prognosis in advanced ovarian carcinoma [J]. J Natl Cancer Inst, 1995,87: 1230-1237.

共引文献7

同被引文献33

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部